Showing results (151-160 of 405) with videos related to

Sort By:
Pageof 41
Pacing and Clinical Electrophysiology : PACE|September 18, 2012
Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysisSaurav Chatterjee, Partha Sardar, Edgar Lichstein, et al.
Dalton Transactions (Cambridge, England : 2003)|October 10, 2024
Synthesis and reactivity of a heteroleptic magnesium hydride on a dearomatized picolyl-based NNN-chelatorChhotan Mandal, Subham Sarkar, Sourav Panda, et al.
Inorganic Chemistry|December 21, 2023
2-Anilidomethylpyridine-Derived Three-Coordinate Zinc Hydride: The Journey Unveils Anilide Backbone's Reactive NatureChhotan Mandal, Shalini Joshi, Sanjay Das, et al.
Chemical Communications (Cambridge, England)|April 3, 2024
Fluorenyl-tethered N-heterocyclic carbene (NHC): an exclusive C-donor ligand for heteroleptic calcium and strontium chemistrySumana Mondal, Subham Sarkar, Chhotan Mandal, et al.
Angewandte Chemie (International Ed. in English)|September 27, 2023
Divergent Synthesis of Chelating Aziridines and Cyclic(Alkyl)(Amino)Carbenes (CAACs) from Pyridyl-Tethered Robust Azomethine YlidesSudip Baguli, Subham Sarkar, Soumajit Nath, et al.
Heart (British Cardiac Society)|December 16, 2010
Contemporary management of concomitant carotid and coronary artery diseaseSridhar Venkatachalam, Bruce H Gray, Debabrata Mukherjee, et al.
JAMA Internal Medicine|December 26, 2012
Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysisSaurav Chatterjee, Jørn Wetterslev, Abhishek Sharma, et al.
Dalton Transactions (Cambridge, England : 2003)|May 4, 2017
Zinc hydridotriphenylborates supported by a neutral macrocyclic polyamineDebabrata Mukherjee, Ann-Kristin Wiegand, Thomas P Spaniol, et al.
Cardiovascular & Hematological Agents in Medicinal Chemistry|September 10, 2011
Optimal medical therapy for coronary artery disease in 2011 - perspectives from the STICH TrialThomas F Whayne, Sibu P Saha, Karla Quevedo, et al.
Cardiovascular & Hematological Disorders Drug Targets|July 5, 2014
Alogliptin; a review of a new dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type 2 diabetes mellitusSarmad Said, Azikiwe C Nwosu, Debabrata Mukherjee, et al.
Pageof 41